{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:02:53Z","timestamp":1790712173284,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.jad.2021.09.055","type":"journal-article","created":{"date-parts":[[2021,9,22]],"date-time":"2021-09-22T02:11:20Z","timestamp":1632276680000},"page":"277-282","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Risk of psychiatric disorders in patients taking isotretinoin: A nationwide, population-based, cohort study in Taiwan"],"prefix":"10.1016","volume":"296","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7019-2357","authenticated-orcid":false,"given":"Yi-Hsien","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6493-1811","authenticated-orcid":false,"given":"Wei-Ming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4576-9900","authenticated-orcid":false,"given":"Chi-Hsiang","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Huei","family":"Tsao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wu-Chien","family":"Chien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7138-7757","authenticated-orcid":false,"given":"Chih-Tsung","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2021.09.055_bib0001","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.jaad.2005.11.1061","article-title":"Low-dose isotretinoin in the treatment of acne vulgaris","volume":"54","author":"Amichai","year":"2006","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jad.2021.09.055_bib0002","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1503\/cmaj.140665","article-title":"Management of acne: Canadian clinical practice guideline","volume":"188","author":"Asai","year":"2016","journal-title":"CMAJ"},{"key":"10.1016\/j.jad.2021.09.055_bib0003","doi-asserted-by":"crossref","first-page":"526","DOI":"10.4088\/JCP.v69n0403","article-title":"Isotretinoin and the risk of depression in patients with acne vulgaris: a case-crossover study","volume":"69","author":"Azoulay","year":"2008","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2021.09.055_bib0004","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/00004850-200501000-00008","article-title":"Affective psychosis following accutane (isotretinoin) treatment","volume":"20","author":"Barak","year":"2005","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2021.09.055_bib0005","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0190-9622(88)70078-X","article-title":"Adverse reactions to isotretinoin. A report from the adverse drug reaction reporting system","volume":"18","author":"Bigby","year":"1988","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jad.2021.09.055_bib0006","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1176\/appi.ajp.162.5.983","article-title":"Functional brain imaging alterations in acne patients treated with isotretinoin","volume":"162","author":"Bremner","year":"2005","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2021.09.055_bib0007","doi-asserted-by":"crossref","first-page":"37","DOI":"10.4088\/JCP.10r05993","article-title":"Retinoic acid and affective disorders: the evidence for an association","volume":"73","author":"Bremner","year":"2012","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2021.09.055_bib0008","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/pds.2087","article-title":"Validation of the national health insurance research database with ischemic stroke cases in Taiwan","volume":"20","author":"Cheng","year":"2011","journal-title":"Pharmacoepidemiol Drug Saf."},{"key":"10.1016\/j.jad.2021.09.055_bib0009","series-title":"Six Countries, Six Reform Models: The Healthcare Reform Experience of Israel","first-page":"171","article-title":"Taiwan's national health insurance system: high value for the dollar","author":"Cheng","year":"2009"},{"key":"10.1016\/j.jad.2021.09.055_bib0010","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1001\/archderm.141.5.557","article-title":"Isotretinoin therapy and mood changes in adolescents with moderate to severe acne: a cohort study","volume":"141","author":"Chia","year":"2005","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.jad.2021.09.055_bib0011","first-page":"e227","article-title":"No association found between patients receiving isotretinoin for acne and the development of depression in a Canadian prospective cohort","volume":"14","author":"Cohen","year":"2007","journal-title":"Can. J. Clin. Pharmacol."},{"key":"10.1016\/j.jad.2021.09.055_bib0012","doi-asserted-by":"crossref","first-page":"407","DOI":"10.4088\/JCP.v60n0611a","article-title":"Isotretinoin treatment of a woman with bipolar disorder","volume":"60","author":"Cott","year":"1999","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2021.09.055_bib0013","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5070\/D34HP8N68P","article-title":"Acne in adolescents: quality of life, self-esteem, mood, and psychological disorders","volume":"17","author":"Dunn","year":"2011","journal-title":"Dermatol. Online J."},{"key":"10.1016\/j.jad.2021.09.055_bib0014","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s40272-019-00340-y","article-title":"Comparison of quality of life, depression, anxiety, suicide, social anxiety and obsessive-compulsive symptoms between adolescents with acne receiving isotretinoin and antibiotics: a prospective, non-randomised, open-label study","volume":"21","author":"Erdo\u011fan","year":"2019","journal-title":"Paediatr. Drugs"},{"key":"10.1016\/j.jad.2021.09.055_bib0015","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jaad.2005.03.029","article-title":"Socioeconomic status influences care of patients with acne in Ontario, Canada","volume":"54","author":"Haider","year":"2006","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jad.2021.09.055_bib0016","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/jid.2010.264","article-title":"Suicidal ideation, mental health problems, and social impairment are increased in adolescents with acne: a population-based study","volume":"131","author":"Halvorsen","year":"2011","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jad.2021.09.055_bib0017","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1001\/archderm.148.1.131","article-title":"A population-based study of acne and body mass index in adolescents","volume":"148","author":"Halvorsen","year":"2012","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.jad.2021.09.055_bib0018","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/S0190-9622(83)80154-6","article-title":"Depression\u2013a side effect of 13-cis-retinoic acid therapy","volume":"9","author":"Hazen","year":"1983","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jad.2021.09.055_bib0019","doi-asserted-by":"crossref","first-page":"5754","DOI":"10.1038\/s41598-020-62715-3","article-title":"Systematic review of the epidemiology of acne vulgaris","volume":"10","author":"Heng","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jad.2021.09.055_bib0020","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1067\/S0190-9622(03)02087-5","article-title":"Isotretinoin and antidepressant pharmacotherapy: a prescription sequence symmetry analysis","volume":"49","author":"Hersom","year":"2003","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jad.2021.09.055_bib0021","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.jaad.2016.12.028","article-title":"Isotretinoin treatment for acne and risk of depression: a systematic review and meta-analysis","volume":"76","author":"Huang","year":"2017","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jad.2021.09.055_bib0022","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1001\/archderm.136.10.1231","article-title":"Isotretinoin use and risk of depression, psychotic symptoms, suicide, and attempted suicide","volume":"136","author":"Jick","year":"2000","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.jad.2021.09.055_bib0023","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1365-4632.2009.03806.x","article-title":"Comparison of depression, anxiety and life quality in acne vulgaris patients who were treated with either isotretinoin or topical agents","volume":"48","author":"Kaymak","year":"2009","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.jad.2021.09.055_bib0024","first-page":"484","article-title":"A prospective study of the responsiveness of depression and suicidal ideation in acne patients to different phases of isotretinoin therapy","volume":"15","author":"Kellett","year":"2005","journal-title":"Eur. J. Dermatol."},{"key":"10.1016\/j.jad.2021.09.055_bib0025","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0377-1237(10)80038-3","article-title":"Toxicity of low-dose intermittent isotretinoin in recalcitrant acne","volume":"66","author":"Kumar","year":"2010","journal-title":"Med. J. Armed Forces India"},{"key":"10.1016\/j.jad.2021.09.055_bib0026","doi-asserted-by":"crossref","first-page":"162","DOI":"10.4161\/derm.1.3.9364","article-title":"The use of isotretinoin in acne","volume":"1","author":"Layton","year":"2009","journal-title":"Dermato-Endocrinology"},{"key":"10.1016\/j.jad.2021.09.055_bib0027","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.sder.2008.03.005","article-title":"Depression and suicidal behavior in acne patients treated with isotretinoin: a systematic review","volume":"26","author":"Marqueling","year":"2007","journal-title":"Semin. Cutan. Med. Surg."},{"key":"10.1016\/j.jad.2021.09.055_bib0028","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jcrc.2004.09.007","article-title":"A systematic review of the Charlson comorbidity index using Canadian administrative databases: a perspective on risk adjustment in critical care research","volume":"20","author":"Needham","year":"2005","journal-title":"J. Crit. Care"},{"key":"10.1016\/j.jad.2021.09.055_bib0029","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3181\/0706-MR-158","article-title":"Retinoid-mediated regulation of mood: possible cellular mechanisms","volume":"233","author":"O'Reilly","year":"2008","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.jad.2021.09.055_bib0030","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1038\/sj.npp.1300998","article-title":"Chronic administration of 13-cis-retinoic acid increases depression-related behavior in mice","volume":"31","author":"O'Reilly","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jad.2021.09.055_bib0031","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1136\/bmj.38987.606701.80","article-title":"Acne","volume":"333","author":"Purdy","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.jad.2021.09.055_bib0032","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1111\/j.1468-3083.2009.03313.x","article-title":"Depressive symptoms and suicidal ideation during isotretinoin treatment: a 12-week follow-up study of male Finnish military conscripts","volume":"23","author":"Rehn","year":"2009","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.jad.2021.09.055_bib0033","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jad.2009.09.005","article-title":"Psychiatric reactions to isotretinoin in patients with bipolar disorder","volume":"122","author":"Schaffer","year":"2010","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2021.09.055_bib0034","doi-asserted-by":"crossref","first-page":"40","DOI":"10.2340\/00015555-1164","article-title":"Prevalence of acne vulgaris in Chinese adolescents and adults: a community-based study of 17,345 subjects in six cities","volume":"92","author":"Shen","year":"2012","journal-title":"Acta Derm. Venereol."},{"key":"10.1016\/j.jad.2021.09.055_bib0035","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1001\/jamadermatol.2019.1416","article-title":"Psychiatric adverse events in patients taking isotretinoin as reported in a food and drug administration database from 1997 to 2017","volume":"155","author":"Singer","year":"2019","journal-title":"JAMA Dermatol."},{"key":"10.1016\/j.jad.2021.09.055_bib0036","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1111\/j.1365-4632.2006.02660.x","article-title":"Isotretinoin and the controversy of psychiatric adverse effects","volume":"45","author":"Strahan","year":"2006","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.jad.2021.09.055_bib0037","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.curtheres.2019.01.008","article-title":"Psychiatric and developmental effects of isotretinoin (retinoid) treatment for acne vulgaris","volume":"90","author":"Suuberg","year":"2019","journal-title":"Curr. Ther. Res. Clin. Exp."},{"key":"10.1016\/j.jad.2021.09.055_bib0038","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/S0140-6736(15)00234-2","article-title":"Suicide and suicidal behaviour","volume":"387","author":"Turecki","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jad.2021.09.055_bib0039","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/bjd.15668","article-title":"Efficacy and adverse events of oral isotretinoin for acne: a systematic review","volume":"178","author":"Vallerand","year":"2018","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jad.2021.09.055_bib0040","first-page":"2341","article-title":"[Psychiatric symptoms during isotretinoin therapy]","volume":"147","author":"van Broekhoven","year":"2003","journal-title":"Ned. Tijdschr. Geneeskd."},{"key":"10.1016\/j.jad.2021.09.055_bib0041","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s40257-019-00489-9","article-title":"Risk for suicidal behavior among psoriasis patients: a nationwide cohort study","volume":"21","author":"Wang","year":"2020","journal-title":"Am. J. Clin. Dermatol."},{"key":"10.1016\/j.jad.2021.09.055_bib0042","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1136\/bmj.325.7362.475","article-title":"Acne vulgaris","volume":"325","author":"Webster","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.jad.2021.09.055_bib0043","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1067\/mjd.2001.117730","article-title":"An analysis of reports of depression and suicide in patients treated with isotretinoin","volume":"45","author":"Wysowski","year":"2001","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jad.2021.09.055_bib0044","doi-asserted-by":"crossref","first-page":"450","DOI":"10.3389\/fpubh.2020.00450","article-title":"A review of advancement on influencing factors of acne: an emphasis on environment characteristics","volume":"8","author":"Yang","year":"2020","journal-title":"Front. Public Health"},{"key":"10.1016\/j.jad.2021.09.055_bib0045","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.jaad.2015.12.037","article-title":"Guidelines of care for the management of acne vulgaris","volume":"74","author":"Zaenglein","year":"2016","journal-title":"J. Am. Acad. Dermatol."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032721010144?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032721010144?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T02:14:39Z","timestamp":1759025679000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032721010144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":45,"alternative-id":["S0165032721010144"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2021.09.055","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk of psychiatric disorders in patients taking isotretinoin: A nationwide, population-based, cohort study in Taiwan","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2021.09.055","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}